First Republic Investment Management Inc. lowered its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 19.4% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 751 shares of the medical instruments supplier’s stock after selling 181 shares during the period. First Republic Investment Management Inc.’s holdings in Mettler-Toledo International were worth $470,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. First Personal Financial Services grew its stake in Mettler-Toledo International by 2.8% during the second quarter. First Personal Financial Services now owns 186 shares of the medical instruments supplier’s stock worth $109,000 after buying an additional 5 shares during the last quarter. Sun Life Financial INC grew its stake in Mettler-Toledo International by 2,585.7% during the second quarter. Sun Life Financial INC now owns 188 shares of the medical instruments supplier’s stock worth $111,000 after buying an additional 181 shares during the last quarter. Acrospire Investment Management LLC bought a new stake in Mettler-Toledo International during the second quarter worth about $118,000. Quantbot Technologies LP bought a new stake in Mettler-Toledo International during the third quarter worth about $193,000. Finally, Conning Inc. bought a new stake in Mettler-Toledo International during the second quarter worth about $206,000. 91.76% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Inc. (NYSE:MTD) opened at $639.94 on Friday. Mettler-Toledo International Inc. has a twelve month low of $408.97 and a twelve month high of $694.48. The firm has a market cap of $16,369.03, a P/E ratio of 37.87, a P/E/G ratio of 2.92 and a beta of 1.09. The company has a quick ratio of 1.11, a current ratio of 1.51 and a debt-to-equity ratio of 2.05.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 2nd. The medical instruments supplier reported $4.36 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $4.32 by $0.04. Mettler-Toledo International had a net margin of 16.44% and a return on equity of 96.81%. The business had revenue of $698.80 million for the quarter, compared to analyst estimates of $685.56 million. During the same period in the prior year, the business posted $3.89 earnings per share. Mettler-Toledo International’s revenue was up 7.4% compared to the same quarter last year. equities analysts predict that Mettler-Toledo International Inc. will post 17.52 EPS for the current fiscal year.

Several analysts have weighed in on the stock. Jefferies Group reaffirmed a “hold” rating and set a $600.00 price objective on shares of Mettler-Toledo International in a research note on Friday, October 20th. Bank of America increased their price target on shares of Mettler-Toledo International from $640.00 to $710.00 and gave the company a “buy” rating in a research note on Monday, October 9th. Morgan Stanley increased their price target on shares of Mettler-Toledo International from $535.00 to $545.00 and gave the company an “equal weight” rating in a research note on Friday, November 3rd. Robert W. Baird increased their price target on shares of Mettler-Toledo International from $605.00 to $675.00 and gave the company a “neutral” rating in a research note on Friday, November 3rd. Finally, Zacks Investment Research raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $711.00 price target on the stock in a research note on Thursday, September 21st. Five investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $621.57.

In other Mettler-Toledo International news, Director Michael A. Kelly sold 3,384 shares of the stock in a transaction on Monday, November 6th. The shares were sold at an average price of $638.24, for a total value of $2,159,804.16. Following the sale, the director now directly owns 4,762 shares in the company, valued at $3,039,298.88. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Shawn Vadala sold 226 shares of the stock in a transaction on Monday, November 13th. The stock was sold at an average price of $629.36, for a total transaction of $142,235.36. Following the completion of the sale, the chief financial officer now owns 5,299 shares in the company, valued at $3,334,978.64. The disclosure for this sale can be found here. Insiders sold 39,969 shares of company stock worth $25,242,999 over the last 90 days. 5.20% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY WARNING: “Mettler-Toledo International Inc. (MTD) Shares Sold by First Republic Investment Management Inc.” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/mettler-toledo-international-inc-mtd-shares-sold-by-first-republic-investment-management-inc/1769690.html.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with Analyst Ratings Network's FREE daily email newsletter.